Lung Function and Respiratory Symptoms in Association with Mortality: The HUNT Study

References

• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD 2011 [updated 11 January 2012 cited 2012 21 May]. Available from: http://www.goldcopd.org.
   Google Scholar
• Fromer L. Diagnosing and treating COPD: understanding the challenges and finding solutions. Inter J Gen Med 2011; 4:729–739.
   PubMedGoogle Scholar
• Yawn BP, Wollan PC. Knowledge and attitudes of family physicians coming to COPD continuing medical education. Int J Chron Obstruct Pulmon Dis 2008; 3(2):311–317.
   PubMedGoogle Scholar
• Gulsvik AK, Gulsvik A, Skovlund E, The association between lung function and fatal stroke in a community followed for 4 decades. J Epidemiol Community Health 2012;66(11):1030–1036.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Diaz-Guzman E, Buist S. Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Respir Res 2011; 12:136.
   PubMed Web of Science ®Google Scholar
• Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127(6):1952–1959.
   PubMed Web of Science ®Google Scholar
• Stavem K, Aaser E, Sandvik L, Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males. Eur Respir J 2005; 25(4):618–625.
   PubMed Web of Science ®Google Scholar
• Schunemann HJ, Dorn J, Grant BJ, Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118(3):656–664.
   PubMed Web of Science ®Google Scholar
• Hole DJ, Watt GC, Davey-Smith G, Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996; 313(7059):711–715.
   PubMed Web of Science ®Google Scholar
• Lange P, Nyboe J, Appleyard M, Spirometric findings and mortality in never-smokers. J Clin Epidemiol 1990; 43(9):867–873.
   PubMed Web of Science ®Google Scholar
• Baughman P, Marott JL, Lange P, Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort. COPD 2011; 8(2):103–113.
   PubMedGoogle Scholar
• Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100(1):115–122.
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6:98.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Buist AS, Petty TL, Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003; 58(5):388–393.
   PubMed Web of Science ®Google Scholar
• Knuiman MW, James AL, Divitini ML, Lung function, respiratory symptoms, and mortality: results from the Busselton Health Study. Ann Epidemiol 1999; 9(5):297–306.
   PubMed Web of Science ®Google Scholar
• Lange P, Nyboe J, Appleyard M, Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45(8):579–585.
   PubMed Web of Science ®Google Scholar
• Vollmer WM, McCamant LE, Johnson LR, Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol 1989; 129(6):1157–1169.
   PubMed Web of Science ®Google Scholar
• Ebi-Kryston KL, Hawthorne VM, Rose G, Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States. Int J Epidemiol.1989; 18(1):84–88.
   PubMed Web of Science ®Google Scholar
• Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. J Clin Epidemiol 1988; 41(3):251–260.
   PubMed Web of Science ®Google Scholar
• Frostad A, Soyseth V, Haldorsen T, Respiratory symptoms and long-term cardiovascular mortality. Respir Med 2007; 101(11):2289–2296.
   PubMed Web of Science ®Google Scholar
• Frostad A, Soyseth V, Andersen A, Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up. J Intern Med 2006; 259(5):520–529.
   PubMed Web of Science ®Google Scholar
• Hewitt J, Smeeth L, Bulpitt CJ, Respiratory symptoms in older people and their association with mortality. Thorax 2005; 60(4):331–334.
   PubMed Web of Science ®Google Scholar
• Carpenter L, Beral V, Strachan D, Respiratory symptoms as predictors of 27 year mortality in a representative sample of British adults. BMJ 1989; 299(6695):357–361.
   PubMed Web of Science ®Google Scholar
• Figarska SM, Boezen HM, Vonk JM. Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study. Eur J Epidemiol 2012; 27(11):867–876.
   PubMed Web of Science ®Google Scholar
• Helseundersøkelsen i Nord-Trøndelag 2012 [updated May 11 2012; cited 2012 May 21]. Available from: http://www.ntnu.edu/hunt.
   Google Scholar
• Krokstad S, Langhammer A, Hveem K, Cohort Profile: The HUNT Study, Norway. Int J Epidemiol [published online ahead of print 9 August 2012]. (doi:10.1093/ije/dys095).
   Google Scholar
• Holmen J, Midthjell K, Krüger Ø, The Nord-Trøndelag Health Study 1995–97 (HUNT 2): Objectives, contents, methods and participation. Norsk Epidemiolog 2003; 13(1):19–32.
   Google Scholar
• Leivseth L, Nilsen TI, Mai XM, Lung function and anxiety in association with dyspnoea: The HUNT study. Respir Med 2012; 106(8):1148–1157.
   PubMed Web of Science ®Google Scholar
• Langhammer A, Johnsen R, Gulsvik A, Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag Study. Eur Respir J 2001; 18(5):770–779.
   PubMed Web of Science ®Google Scholar
• Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152(3):1107–1136.
   Google Scholar
• Brogger JC, Bakke PS, Gulsvik A. Comparison of respiratory symptoms questionnaires. Int J Tuberc Lung Dis 2000; 4(1):83–90.
   PubMed Web of Science ®Google Scholar
• Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res [published online ahead of print January 10, 2011]. (doi:10.1177/0962280210395740).
   Web of Science ®Google Scholar
• Becklake MR, Kauffmann F. Gender differences in airway behaviour over the human life span. Thorax 1999; 54(12):1119–1138.
   PubMed Web of Science ®Google Scholar
• Hernán MA, Robins JM. Causal Inference 2012 [updated 2012 Nov 25 cited 2012 Des 11]. Available from: http://www.hsph.harvard.edu/faculty/miguel-hernan/files/hernanrobins_v1.10.19.pdf.
   Google Scholar
• Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
   Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33(5):1165–1185.
   PubMed Web of Science ®Google Scholar
• Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 1999; 159(1):321–340.
   PubMed Web of Science ®Google Scholar
• Langhammer A, Johnsen R, Holmen J, Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trøndelag Health Study (HUNT). J Epidemiol Commun Health 2000; 54(12):917–922.
   PubMed Web of Science ®Google Scholar